Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Allied Healthcare International Inc. (“Allied Healthcare” or the “Company”) (NASDAQ: AHCI) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Saga Group Ltd. in an all-cash deal for about $175 million. Under the terms of the proposed transaction, which were unanimously approved by the Company’s Board of Directors, Allied Healthcare stakeholders will receive $3.90 in cash for each share of Allied Healthcare common stock. The transaction is expected to close in the fourth calendar quarter of 2011.

Request more information now by clicking here: www.faruqilaw.com/AHCI

Whether Allied Healthcare’s Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, whether the proposed transaction undervalues Allied Healthcare’s shares and by how much this proposed transaction undervalues the Company to the detriment of Allied Healthcare’s shareholders are the key focus of this investigation.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, through all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients.

If you own common stock in Allied Healthcare and wish to obtain additional information, please visit us at www.faruqilaw.com/AHCI or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.

Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.